Cannabinoids and Dementia: A Review of Clinical and Preclinical Data.
about
Natural Phytochemicals in the Treatment and Prevention of Dementia: An OverviewAgitation in Alzheimer Disease as a Qualifying Condition for Medical Marijuana in the United States.Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study.Combined Donepezil and Ethanolic Extract of Propolis Improved Memory Better Than Donepezil and Propolis Monotherapy in Wild Type
P2860
Cannabinoids and Dementia: A Review of Clinical and Preclinical Data.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Cannabinoids and Dementia: A Review of Clinical and Preclinical Data.
@ast
Cannabinoids and Dementia: A Review of Clinical and Preclinical Data.
@en
type
label
Cannabinoids and Dementia: A Review of Clinical and Preclinical Data.
@ast
Cannabinoids and Dementia: A Review of Clinical and Preclinical Data.
@en
prefLabel
Cannabinoids and Dementia: A Review of Clinical and Preclinical Data.
@ast
Cannabinoids and Dementia: A Review of Clinical and Preclinical Data.
@en
P2860
P356
P1433
P1476
Cannabinoids and Dementia: A Review of Clinical and Preclinical Data.
@en
P2093
Michael Halpern
P2860
P304
P356
10.3390/PH3082689
P577
2010-08-17T00:00:00Z